Preventative Cognitive Behavioral Therapy for Insomnia for Insomnia

Phase-Based Progress Estimates
Henry Ford Columbus Medical Center, Novi, MI
Insomnia+1 More
pCBT-I - Behavioral
All Sexes
What conditions do you have?

Study Summary

This study is intended to assess the efficacy of preventative Cognitive Behavioral Therapy for Insomnia (pCBT-I) on reducing the severity and stopping the progression of acute insomnia and depression. We also hope to gain a deeper understanding of the sociocultural, interpersonal, and individual factors that may have a role in development of insomnia and/or engagement with treatment plans.

Eligible Conditions

  • Insomnia

Treatment Effectiveness

Study Objectives

4 Primary · 2 Secondary · Reporting Duration: Through study completion, an average of 1 year

6 months post-treatment
Cases of DSM-5 Insomnia
6-months post-treatment
Cases of Clinically Significant Depression
Year 1
Physical Environment
Sociocultural Environment
up to one year post-treatment
Depression Severity
Insomnia Severity

Trial Safety

Trial Design

2 Treatment Groups

Digital Sleep Education Control
1 of 2
Preventative Cognitive Behavioral Therapy for Insomnia
1 of 2
Active Control
Experimental Treatment

280 Total Participants · 2 Treatment Groups

Primary Treatment: Preventative Cognitive Behavioral Therapy for Insomnia · No Placebo Group · N/A

Preventative Cognitive Behavioral Therapy for Insomnia
Experimental Group · 1 Intervention: pCBT-I · Intervention Types: Behavioral
Digital Sleep Education ControlNoIntervention Group · 1 Intervention: Digital Sleep Education Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 1 year

Trial Background

Philip Cheng, Principal Investigator
Principal Investigator
Henry Ford Health System
Closest Location: Henry Ford Columbus Medical Center · Novi, MI
N/AFirst Recorded Clinical Trial
2 TrialsResearching Insomnia
0 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are experiencing symptoms of prodromal acute insomnia.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.